Andrew Regan

Andrew Regan is recorded as CEO at CDT Equity Inc. (CDT) since April 15, 2025 and Board Member at CDT Equity Inc. (CDT) since September 22, 2023. CDT Equity Inc. reported in an 8-K filed September 1, 2026 that Andrew Regan resigned as Board of Directors, effective August 31, 2026. CDT Equity Inc. reported in an 8-K filed September 1, 2026 that Andrew Regan resigned as Chief Executive Officer, effective August 31, 2026. CDT Equity Inc. reported in an 8-K filed April 16, 2025 that Andrew Regan was appointed Chief Executive Officer, effective April 15, 2025. Equibles holds 4 filed executive changes naming Andrew Regan; each is listed under recent activity with its source filing. The proxy statement of CDT Equity Inc. reports total compensation of $8,168,796 for Andrew Regan in fiscal 2025. CDT Equity Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CDT Equity Inc. includes David Tapolczay (CEO and Board Member), James Bligh (CEO, CFO and Board Member), Chele Chiavacci Farley (Chairman and Board Member) and 6 others.